Sanford-Burnham News Archive

Burnham to Host First Research Briefing on Diabetes

ORLANDO, Fla. , February 20, 2008

Burnham Institute for Medical Research at Lake Nona will host the first Burnham Research Briefing on March 5th featuring Dr. Pamela Itkin-Ansari, a Burnham scientist specializing in Diabetes research. Dr. Itkin-Ansari’s topic will be “The Future of Cell Replacement Therapies for Diabetes.”

This research briefing is the first of four community outreach programs planned in Central Florida that will highlight some of Burnham’s major priorities in medical research.

Dr. Itkin-Ansari will explain how cutting edge technology is being used in the fight against both adult and juvenile forms of the growing health problem. This free event is open to the greater Orlando community and is designed to explain how Burnham researchers are finding new ways of combating diabetes.

A Burnham research scientist since 2005, Dr. Itkin-Ansari said she is enthusiastic about diabetes research at Burnham and the impact it will have on patients, especially a growing number of pediatric patients who suffer the effects of Adult Diabetes. Dr. Itkin-Ansari’s research focuses on the use of human cells to deliver natural insulin to patients instead of through artificial means (pills and injections).

“The Burnham Research Institute in Orlando is an important study center for obesity, as well as for research of the growing threat of Diabetes in children.” said Dr. Itkin-Ansari. “I am very optimistic about the potential breakthrough research on the treatment of the disease.” Dr. Itkin-Ansari recently was awarded the 2008 Health Leadership Award from the Juvenile Diabetes Research Foundation.

The research briefing will take place at 6:00 p.m. at the Renaissance Senior Center, 3800 South Econlockhatchee Trail, Orlando, FL 32829. For more information, please contact Eshma Harry at (407) 745-2061 or via e-mail at

About Sanford-Burnham Medical Research Institute

Sanford-Burnham Medical Research Institute is dedicated to discovering the fundamental molecular causes of disease and devising the innovative therapies of tomorrow. Sanford-Burnham takes a collaborative approach to medical research with major programs in cancer, neurodegeneration and stem cells, diabetes, and infectious, inflammatory, and childhood diseases. The Institute is recognized for its National Cancer Institute-designated Cancer Center and expertise in drug discovery technologies. Sanford-Burnham is a nonprofit, independent institute that employs more than 1,000 scientists and staff in San Diego (La Jolla), Calif., and Orlando (Lake Nona), Fla. For more information, visit us at

Sanford-Burnham can also be found on Facebook at and on Twitter @sanfordburnham.

News & News and Press - Sanford-Burnham Boilerplate
Sign In Skip Navigation Links Skip navigation links
News Archive
Sanford-Burnham In The News
Media Contacts and Guidelines
News Search
Paper of the Week
Quarterly Science Highlights
Multimedia Resources